According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...
The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...
A study presented at SABCS 2024 reveals that active monitoring provides similar quality-of-life outcomes as surgery for patients with low-risk DCIS.
Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...
For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...
Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who ...
DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.
An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...